News

With approval, the new implant becomes the first approved for lowering IOP in patients with open-angle glaucoma and ocular hypertension.

Part 1 of the feature series includes a conversation with Anna Lembke, MD, on the most impactful players and products of the 30-year crisis.

Low fecal intestinal secretory immunoglobin A is commonly found in infants of mothers in the antepartum and persistent depression trajectories.

The label update comes after findings have repeatedly shown an associated risk of neuropsychiatric events.

A new study is diving into differences in long-term outcomes, including remission rates and weight loss, seen among patients undergoing RYGB and SG.

A Mayo Clinic analysis is shedding light on the real-world success of ablation in lowering risk of mortality and HF hospitalizations.

New data evidences yet another IL-13 targeting biologic for atopic dermatitis.

The program can help health systems address the opioid epidemic in the US.

New data from EPI Lifestyle Conference 2020 is shedding light on the impact of initiating estradiol therapy closer to the onset of menopause.

Exercise training could help individuals in the military maintain function despite a lack of regular sleep.

An analysis of 180,000 patients in South Korea is shedding new light on the potential poor oral hygiene can have on a person's risk of diabetes.

Preliminary data shows blue therapy results in a significant decline in raw depression scores when compared to a placebo.

Approval of isatuximab-irfc (Sarclisa) was based on the results of a 307-person trial, according to a statement from the FDA.

The US Preventive Services Task Force suggested that patients 18-79 years old should be screened regardless of known risk factors.

Everyone has an opinion. But what do the actual experts think?

New data from Brigham and Women's Hospital suggests sleep irregularity could be a risk factor for cardiovascular disease.

Prescriptions for antipsychotic medications are commonly used to treat several different brain disorders.

Analysis of more than 13k patients from Taiwan found a vegetarian diet was linked to a lower risk of incident stroke events later in life.

The expert-led narrative series will seek to answer when and how the development of opioids led to a public health crisis.

Sika Dunyoh, director of education programs with NORD, discusses that year in rare disease and what to expect moving forward.

The RareWear program is designed to bridge medical device companies to rare disease patient applicants, seeking better disease and treatment monitoring.

Advanced cystic fibrosis liver disease manifests as portal hypertension with or without cirrhosis in about 7% of patients with cystic fibrosis.

New research suggests proposals aimed at reducing out of pocket costs may harm minimally-funded drug developers.

An emphasis on collecting and assessing quality-of-life biomarkers shows promise for tailoring treatment of the rare condition.

Though weekly activity has slowed, experts insist the national activity remains high overall.

Younger hepatitis B patients had better odds at transplant-free survival after 6 months.

A new study examines how different types of chronic conditions were associated with different increases in risk of visual impairment.

Cerebrospinal fluid storage time did not influence the tested biomarker levels in narcolepsy type 1 patients.